Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system by Jingrong Yang, Mengfan You, Jingxin Wang, Rongfei Sun, Lili Han, Xiaonan Liu, Kaibin Niu, Kaidi Xing, Juanping Sun, Wenge Su, Yifei Wang

Subjects: Get full text

Food Traceability Rule Overview: A Guide for Florida Food Industry by Sharon Chuah, Razieh Farzad

Subjects: Get full text

A year in review: new treatments and expanded indications in dermatology in 2024 by Lauren N. McGrath, Lila G. McGrath, John R. Edminister

Subjects: “…FDA approvals…”
Get full text

Fisher Discriminant Analysis for Extracting Interpretable Phenological Information From Multivariate Time Series Data by Conor T. Doherty, Meagan S. Mauter

Subjects: “…Fisher discriminant analysis (FDA)…”
Get full text

FDA-MIMO Radar Rapid Target Localization via Reconstructed Reduce Dimension Rooting by Cheng Wang, Zhi Zheng, Wen-Qin Wang

Subjects: “…FDA-MIMO radar…”
Get full text

A comprehensive overview of selective and novel fibroblast growth factor receptor inhibitors as a potential anticancer modality by Jain Nem Kumar, Tailang Mukul, Thangavel Neelaveni, Makeen Hafiz A., Albratty Mohammed, Najmi Asim, Alhazmi Hassan Ahmad, Zoghebi Khalid, Alagusundaram Muthumanickam, Jain Hemant Kumar, Chandrasekaran Balakumar

Subjects: Get full text

Adverse events in the nervous system associated with blinatumomab: a real-world study by Wen Gao, Jingwei Yu, Yifei Sun, Zheng Song, Xia Liu, Xue Han, Lanfan Li, Lihua Qiu, Shiyong Zhou, Zhengzi Qian, Xianhuo Wang, Huilai Zhang

Subjects: Get full text

Precision Adverse Drug Reactions Prediction with Heterogeneous Graph Neural Network by Yang Gao, Xiang Zhang, Zhongquan Sun, Payal Chandak, Jiajun Bu, Haishuai Wang

Subjects: Get full text

Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors by Yuhui Yang, Yuhui Yang, Yuhui Yang, Pingping Long, Pingping Long, Ying Tuo, Ying Tuo, Xiaoxiao Wang

Subjects: Get full text

Proton pump inhibitor leaflets: Is there information on deprescribing? by Marcus Vinícius Lopes Campos, Farah Maria Drumond Chequer, Luanna Gabriella Resende da Silva, André Oliveira Baldoni

Subjects: “…Food and Drug Administration (FDA)…”
Get full text

Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA... by Ruichen Gao, Wenjun Liang, Jintao Chen, Mingxia Yang, Xiaowei Yu, Xiaohua Wang

Subjects: “…FDA adverse event reporting system…”
Get full text